Ethical and good publishing practice

Ethics in publishing

TECNOCIENCIA CHIHUAHUA accepts contributions (research articles, scientific notes, and review articles) based on the trust and honesty of the authors; therefore, the information published is the responsibility of the authors.

TECNOCIENCIA CHIHUAHUA encourages authors, reviewers and editors to follow the guidelines for authors and the guidelines and instructions for reviewers. These guidelines are designed to structure manuscripts and reviews in accordance with the good publishing practices outlined in the ethics section and our journal's policies.

Authorship

All authors should have made substantial contributions to all of the following
1. Conception and design of the study, or acquisition of data, or analysis and interpretation of data.
2. Drafting the article or revising it critically for important intellectual content.
3. Final approval of the version to be submitted for publication.
All authors should agree to take responsibility for all aspects of the work to ensure that questions about the accuracy or integrity of any part of the work are appropriately investigated and resolved. (Letter of Authorship or Presentation of the Article)

Changes to authorship

In general, the editors of TECNOCIENCIA CHIHUAHUA will not consider changes in authorship after a manuscript has been submitted. It is important that authors carefully consider the list and order of authors and provide a definitive list of authors in the initial submission. Authors may, however, request the withdrawal or adjustment of authorships by providing the Editorial Board of the journal with solid justification.

Withdrawal of published articles

Withdrawal of a published article is possible only upon explicit request of the authors and/or editors. Withdrawal will only be granted in the case of proven major flaws such as: lack of scientific rigor or reports of non fidelity or non-reproducibility of reported methods and results.

Plagiarism detection

TECNOCIENCIA CHIHUAHUA, uses iThenticate anti-plagiarism software as a service to prevent plagiarism. In the event that the papers submitted for review are outside the limits of similarity with other works (less than 10 %), they will not be submitted for review and will be returned to the author, who will be denied the right to publish in this journal in the event of recurrence.

In addition, the Editorial Board reserves the right to withdraw an article or to publish an erratum in the event of serious, profound observations on an article already published.

Declaration of generative AI in scientific writing

Authors must declare the use of generative AI in scientific writing at the time of submission. Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language of the manuscript, and not to use AI tools to analyze and derive insights from data as part of the research process.

To protect the rights of authors and the confidentiality of their research, TECNOCIENCIA CHIHUAHUA does not currently allow the use of Generative AI or AI-assisted technologies such as ChatGPT or similar services by reviewers or editors in the peer review and manuscript evaluation process. We are actively evaluating compliant AI tools and may revise this policy in the future.

Research ethics approval

Research Involving Human Subjects

When reporting research involving human subjects, or human data, authors must state that the research was conducted in accordance with the tenets of the World Medical Association Declaración of Helsinki : Ethical principles for medical research involving human subjects. In accordance with paragraph 23 of this statement, prior to conducting research, approval must be obtained from the Local Institutional Review Board or other appropriate Ethics Committee to confirm that the study complies with national and international guidelines.

For all studies involving human organs or tissues, there must be sufficient evidence that they were obtained in accordance with the WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. The source of organs or tissues used in clinical research must be transparent and traceable, in accordance with the recommendations of Global Rights Compliance on Mitigating Human Rights Risks in Transplantation Medicine.

Manuscripts should follow the recommendations of the International Committee of Medical Journal Editors (ICMJE) for the conduct, reporting, editing, and publication of scientific work in medical journals and should aim to be representative of human populations in terms of sex, age, and ethnicity. Sex and gender terms should be used correctly as outlined by the World Health Organization (WHO). For more information, please refer to the SAGER guidelines rationale and usage recommendations.

If the study reports on research with vulnerable groups, an additional review may be performed. The submitted manuscript will be reviewed by the Editorial Office and, upon request, supporting documentation (blank informed consent forms and any related ethics committee discussion documents) must be provided. In addition, if studies describe groups by race, ethnicity, gender, disability, disease, etc., an explanation of why such categorization was necessary must be clearly stated in the article.

To the extent possible, subject data should be anonymized; for example, age, ethnicity, or occupation should not be mentioned if they are not relevant to the conclusions.

Studies in animals

All animal experiments should comply with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.

Studies should be conducted in accordance with the Guidance on the operation of the Animals (Scientific Procedures) Act 1986 and associated guidelines, EU Directive 2010/63 on the protection of animals used for scientific purposes, or the NIH (National Research Council) Guide for the Care and Use of Laboratory Animals.

Clinical Trial Registration

Clinical trials must be pre-registered with a public trial registry. A list of acceptable registries can be found at WHO Clinical-trials-registry.

Cell Line Research

Methods sections for submissions reporting research using cell lines should indicate the origin of any cell lines. For established cell lines, the origin should be stated and references should be provided either to a published paper or to a commercial source. If previously unpublished de novo cell lines have been used, including those donated by another laboratory, details of institutional review board or ethics committee approval must be provided, and confirmation of written informed consent must be provided if the line is of human origin.

The editors reserve the right to reject any submission that does not meet these requirements.